APA-referens (7:e uppl.)

Astermark, J., Wojciechowski, P., Aballéa, S., Hakimi, Z., Nazir, J., & Klamroth, R. (2021). Efficacy of rfixfc versus rix-fp for the treatment of patients with hemophilia b. Journal of Blood Medicine, 12, 613. https://doi.org/10.2147/JBM.S312885

Chicago-referens (17:e uppl.)

Astermark, Jan, Piotr Wojciechowski, Samuel Aballéa, Zalmai Hakimi, Jameel Nazir, och Robert Klamroth. "Efficacy of Rfixfc Versus Rix-fp for the Treatment of Patients with Hemophilia B." Journal of Blood Medicine 12 (2021): 613. https://doi.org/10.2147/JBM.S312885.

MLA-referens (9:e uppl.)

Astermark, Jan, et al. "Efficacy of Rfixfc Versus Rix-fp for the Treatment of Patients with Hemophilia B." Journal of Blood Medicine, vol. 12, 2021, p. 613, https://doi.org/10.2147/JBM.S312885.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.